Fed. Circ. Finds Stroke Treatment Patent Anticipated By Study

Law360, New York (May 9, 2012, 7:28 PM EDT) -- The Federal Circuit ruled Tuesday that a patent application for a method of treating strokes was invalid because it was "inherently anticipated" by an earlier study.

In a split decision, the court upheld a decision by the Board of Patent Appeals and Interferences rejecting the application, by Hugh Edward Montgomery and other inventors, based on the inherent anticipation doctrine.

Under that doctrine, newly discovered results of known processes directed to the same purpose are not patentable because such results are inherent, the court ruled, and it...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.